ArticleCancers2023

Administration of Enfortumab Vedotin after Immune-Checkpoint Inhibitor and the Prognosis in Japanese Metastatic Urothelial Carcinoma: A Large Database Study on Enfortumab Vedotin in Metastatic Urothelial Carcinoma.

Takashi Kawahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.